Latest Non-Hodgkin lymphoma Stories
Researchers at North Carolina State University are narrowing the search for genes involved in non-Hodgkin lymphoma â€“ by turning dogs into humans.
SAN DIEGO, Feb. 16, 2011 /PRNewswire/ -- Halozyme Therapeutics, Inc.
ORLANDO, Fla. and SUNNYVALE, Calif., Dec. 7, 2010 /PRNewswire-FirstCall/ -- Pharmacyclics, Inc.
SEATTLE, Nov. 18, 2010 /PRNewswire/ -- Cell Therapeutics, Inc.
Long-term use of statins is unlikely to substantially increase or decrease overall cancer risk, but was associated with lowering risk of melanoma, endometrial cancer and non-Hodgkin lymphoma.
Diffuse large B-cell lymphoma (DLBCL) is a type of aggressive non-Hodgkin's lymphoma that accounts for approximately 40 percent of lymphomas among adults.
Diffuse large B cell lymphoma (DLBCL) is the most common form of non-Hodgkin lymphoma.
NEW YORK, Sept. 21 /PRNewswire/ -- While general awareness of lymphoma remains high, a new survey released today by the Lymphoma Research Foundation (LRF) reveals significant knowledge gaps among Americans about the disease, which is the most prevalent form of blood cancer in the United States.
New National Survey Uncovers Patients' Need for More Lymphoma Resources to Effectively Participate in Their Care NEW YORK, Sept.
Tokyo, Sept 7, 2010 - (JCN Newswire) - SymBio Pharmaceuticals Limited and Eisai Co., Ltd. announced today that Eisai's Singapore subsidiary Eisai (Singapore) Pte. Ltd.